Impact of urethral dilatation and use of moolak tail on urethral stricture

Exploratory study to evaluate the efficacy of uttarbasti using moolak taila and urethral dilatation in urethral stricture - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/082149

Enrollment

Registered

2025-03-11

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N350- Post-traumatic urethral stricture

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: A substantial hemorrhage into the urinary tract. Pain and inflammation in the urethra. Patients who will give written consent. Patients with classical signs and symptoms of urethral stricture will be included in the trial.

Exclusion criteria

Exclusion criteria: Urethral diverticulum. Periurethral abscess. Urethral fistula. Urinary tract infection

Design outcomes

Primary

Measure	Time frame
Decreased urine stream. Incomplete bladder emptying. Spraying of the urine stream. Difficulty, straining or pain when urinating. Increased urge to urinate or more-frequent urination. Burning sensationTimepoint: 60 days	—

Secondary

Measure	Time frame
Retention of urine due to urethral stricture. Urethral catheter is not passing easily. Investigate patients as per requirement of ascending urethrogramTimepoint: 60 days	—

Countries

India

Contacts

Public ContactProf Dr Rajesh Kumar Gupta

Post Graduate Institute of Ayurved Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University jodhpur

guptadrrajeshkumargupta@gmail.com9636520573

Outcome results